Search research articles
Contact Us
Filters
Showing results (251-260 of 271) with videos related to
Page
of 28
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
Breast Cancer Research and Treatment
|
October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Blood
|
September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
Edo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Blood
|
August 15, 2002
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)
Urban Novak, Elisabeth Oppliger Leibundgut, Jörg Hager, et al.
Blood
|
July 5, 2005
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
Bronno van der Holt, Bob Löwenberg, Alan K Burnett, et al.
Blood
|
February 21, 2004
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule
Michele Ghielmini, Shu-Fang Hsu Schmitz, Sergio B Cogliatti, et al.
British Journal of Cancer
|
November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer
J Bernhard, D Zahrieh, A S Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
S K Metzelder, T Schroeder, M Lübbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
Günther Gruber, Marco Bonetti, M Laura Nasi, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 271) with videos related to
Sort By:
Page
of 28
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1997
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI
A Goldhirsch, R D Gelber, M Castiglione, et al.
Breast Cancer Research and Treatment
|
October 28, 2008
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
Olivia Pagani, Shari Gelber, Edda Simoncini, et al.
Blood
|
September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
Edo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Blood
|
August 15, 2002
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)
Urban Novak, Elisabeth Oppliger Leibundgut, Jörg Hager, et al.
Blood
|
July 5, 2005
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
Bronno van der Holt, Bob Löwenberg, Alan K Burnett, et al.
Blood
|
February 21, 2004
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule
Michele Ghielmini, Shu-Fang Hsu Schmitz, Sergio B Cogliatti, et al.
British Journal of Cancer
|
November 17, 2004
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer
J Bernhard, D Zahrieh, A S Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2017
Long-term survival of sorafenib-treated FLT3-ITD-positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
S K Metzelder, T Schroeder, M Lübbert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
G Gruber, B F Cole, M Castiglione-Gertsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI
Günther Gruber, Marco Bonetti, M Laura Nasi, et al.
Page
of 28